$SLNG
Stabilis Solutions Inc

2024 Q3 Form 10-Q Financial Statement

#000143774924025209 Filed on August 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $18.60M
YoY Change 44.09%
Cost Of Revenue $13.55M
YoY Change 28.01%
Gross Profit $5.048M
YoY Change 117.4%
Gross Profit Margin 27.14%
Selling, General & Admin $3.331M
YoY Change 9.46%
% of Gross Profit 65.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.800M
YoY Change -10.0%
% of Gross Profit 35.66%
Operating Expenses $3.331M
YoY Change 9.46%
Operating Profit $1.717M
YoY Change -338.14%
Interest Expense $405.0K
YoY Change -45.12%
% of Operating Profit 23.59%
Other Income/Expense, Net $54.00K
YoY Change -125.59%
Pretax Income $452.0K
YoY Change -122.43%
Income Tax $425.0K
% Of Pretax Income 94.03%
Net Earnings $27.00K
YoY Change -101.24%
Net Earnings / Revenue 0.15%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 18.59M 18.59M
Diluted Shares Outstanding 18.59M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.48M
YoY Change 41.4%
Cash & Equivalents $11.48M
Short-Term Investments
Other Short-Term Assets $145.0K
YoY Change 113.24%
Inventory $155.0K
Prepaid Expenses
Receivables $5.933M
Other Receivables $284.0K
Total Short-Term Assets $18.90M
YoY Change 35.15%
LONG-TERM ASSETS
Property, Plant & Equipment $48.37M
YoY Change -6.07%
Goodwill $4.314M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $10.54M
YoY Change -7.04%
Other Assets
YoY Change
Total Long-Term Assets $63.68M
YoY Change -5.94%
TOTAL ASSETS
Total Short-Term Assets $18.90M
Total Long-Term Assets $63.68M
Total Assets $82.57M
YoY Change 1.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.607M
YoY Change 266.04%
Accrued Expenses $3.614M
YoY Change -64.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $1.216M
YoY Change -22.7%
Total Short-Term Liabilities $11.52M
YoY Change -16.04%
LONG-TERM LIABILITIES
Long-Term Debt $7.378M
YoY Change -11.63%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $7.378M
YoY Change -11.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.52M
Total Long-Term Liabilities $7.378M
Total Liabilities $18.90M
YoY Change -14.69%
SHAREHOLDERS EQUITY
Retained Earnings -$38.75M
YoY Change -6.54%
Common Stock $19.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $63.68M
YoY Change
Total Liabilities & Shareholders Equity $82.57M
YoY Change 1.1%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $27.00K
YoY Change -101.24%
Depreciation, Depletion And Amortization $1.800M
YoY Change -10.0%
Cash From Operating Activities $5.038M
YoY Change 32.27%
INVESTING ACTIVITIES
Capital Expenditures $1.376M
YoY Change -7.28%
Acquisitions
YoY Change
Other Investing Activities $72.00K
YoY Change
Cash From Investing Activities -$1.304M
YoY Change -12.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -529.0K
YoY Change -50.93%
NET CHANGE
Cash From Operating Activities 5.038M
Cash From Investing Activities -1.304M
Cash From Financing Activities -529.0K
Net Change In Cash 3.205M
YoY Change 157.02%
FREE CASH FLOW
Cash From Operating Activities $5.038M
Capital Expenditures $1.376M
Free Cash Flow $3.662M
YoY Change 57.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
Stabilis Solutions, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001043186
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
37500000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
37500000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18585014
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18585014
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18573391
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18573391
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
65000 usd
CY2021Q2 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#PrimeRateMember
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40364
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3410234
dei Entity Address Address Line1
EntityAddressAddressLine1
11750 Katy Freeway, Suite 900
dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77079
dei City Area Code
CityAreaCode
832
dei Local Phone Number
LocalPhoneNumber
456-6500
dei Security12b Title
Security12bTitle
Common Stock, $.001 par value
dei Trading Symbol
TradingSymbol
SLNG
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18585014
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11483000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5374000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5933000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7752000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
155000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
169000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1325000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1677000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
18896000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
14972000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
110426000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
110646000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62057000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
61167000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48369000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49479000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
4314000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
4314000 usd
CY2024Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
10541000 usd
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
12009000 usd
CY2024Q2 slng Right Of Use Assets And Other Assets Noncurrent
RightOfUseAssetsAndOtherAssetsNoncurrent
453000 usd
CY2023Q4 slng Right Of Use Assets And Other Assets Noncurrent
RightOfUseAssetsAndOtherAssetsNoncurrent
525000 usd
CY2024Q2 us-gaap Assets
Assets
82573000 usd
CY2023Q4 us-gaap Assets
Assets
81299000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6607000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5707000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3614000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4166000 usd
CY2024Q2 slng Finance Lease And Operating Lease Liability Current
FinanceLeaseAndOperatingLeaseLiabilityCurrent
82000 usd
CY2023Q4 slng Finance Lease And Operating Lease Liability Current
FinanceLeaseAndOperatingLeaseLiabilityCurrent
164000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11519000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11719000 usd
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
7378000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
7747000 usd
CY2024Q2 slng Finance Lease And Operating Lease Liability Noncurrent
FinanceLeaseAndOperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q4 slng Finance Lease And Operating Lease Liability Noncurrent
FinanceLeaseAndOperatingLeaseLiabilityNoncurrent
21000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
18897000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
19487000 usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
19000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
19000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102839000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102057000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-432000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-18000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38750000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40246000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
63676000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
61812000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82573000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81299000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18598000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12907000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38368000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39749000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
13550000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
10585000 usd
us-gaap Cost Of Revenue
CostOfRevenue
27064000 usd
us-gaap Cost Of Revenue
CostOfRevenue
30855000 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
82000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
224000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
334000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
55000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3331000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3043000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6787000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6422000 usd
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
72000 usd
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
199000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1768000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1992000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3568000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4003000 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
18495000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
15396000 usd
us-gaap Costs And Expenses
CostsAndExpenses
36886000 usd
us-gaap Costs And Expenses
CostsAndExpenses
41225000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
103000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2489000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1482000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1476000 usd
CY2024Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
340000 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
741000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
587000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1134000 usd
CY2024Q2 slng Operations Related Expense Foreign Joint Venture
OperationsRelatedExpenseForeignJointVenture
45000 usd
CY2023Q2 slng Operations Related Expense Foreign Joint Venture
OperationsRelatedExpenseForeignJointVenture
56000 usd
slng Operations Related Expense Foreign Joint Venture
OperationsRelatedExpenseForeignJointVenture
95000 usd
slng Operations Related Expense Foreign Joint Venture
OperationsRelatedExpenseForeignJointVenture
104000 usd
CY2024Q2 slng Equity Income Foreign Joint Venture Net
EquityIncomeForeignJointVentureNet
295000 usd
CY2023Q2 slng Equity Income Foreign Joint Venture Net
EquityIncomeForeignJointVentureNet
685000 usd
slng Equity Income Foreign Joint Venture Net
EquityIncomeForeignJointVentureNet
492000 usd
slng Equity Income Foreign Joint Venture Net
EquityIncomeForeignJointVentureNet
1030000 usd
CY2024Q2 slng Income Loss From Continuing Operations Before Nonoperating Income Expense Income Taxes Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeNonoperatingIncomeExpenseIncomeTaxesNoncontrollingInterest
398000 usd
CY2023Q2 slng Income Loss From Continuing Operations Before Nonoperating Income Expense Income Taxes Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeNonoperatingIncomeExpenseIncomeTaxesNoncontrollingInterest
-1804000 usd
slng Income Loss From Continuing Operations Before Nonoperating Income Expense Income Taxes Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeNonoperatingIncomeExpenseIncomeTaxesNoncontrollingInterest
1974000 usd
slng Income Loss From Continuing Operations Before Nonoperating Income Expense Income Taxes Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeNonoperatingIncomeExpenseIncomeTaxesNoncontrollingInterest
-446000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-40000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-124000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
54000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-211000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
29000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-477000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
452000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2015000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2003000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-923000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
425000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
159000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
507000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
167000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
27000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2174000 usd
us-gaap Net Income Loss
NetIncomeLoss
1496000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1090000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
27000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2174000 usd
us-gaap Net Income Loss
NetIncomeLoss
1496000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1090000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
52000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-618000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-414000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-431000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
79000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2792000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1082000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1521000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
59867000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
589000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1084000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
187000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
61727000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
593000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2174000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-618000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
59528000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
61812000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
383000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1469000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-466000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
63189000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
408000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
27000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
52000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
63676000 usd
us-gaap Net Income Loss
NetIncomeLoss
1496000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1090000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3568000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4003000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
791000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1182000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
68000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
199000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
587000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1134000 usd
slng Cash Settlements From Derivatives
CashSettlementsFromDerivatives
-359000 usd
slng Cash Settlements From Derivatives
CashSettlementsFromDerivatives
0 usd
us-gaap Realized And Unrealized Gain Loss Investment And Derivative Operating After Tax
RealizedAndUnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax
-30000 usd
us-gaap Realized And Unrealized Gain Loss Investment And Derivative Operating After Tax
RealizedAndUnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax
-491000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1716000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
813000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1736000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7008000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-680000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-827000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-133000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8385000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-160000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-187000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8967000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3902000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2249000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5211000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
279000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1970000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5211000 usd
slng Repayments Of Shortterm And Longterm Notes Payable
RepaymentsOfShorttermAndLongtermNotesPayable
875000 usd
slng Repayments Of Shortterm And Longterm Notes Payable
RepaymentsOfShorttermAndLongtermNotesPayable
731000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1200000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
108000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-884000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2039000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6109000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3330000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5374000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11451000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11483000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8121000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates in the Preparation of the Consolidated Financial Statements </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:23pt;">The preparation of the Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates include the fair value of natural gas derivatives, the carrying amount of contingencies, valuation allowances for receivables, inventories, and deferred income tax assets, valuations assigned to assets and liabilities in business combinations, and impairments of long-lived assets. Actual results could differ from those estimates, and these differences could be material to the Condensed Consolidated Financial Statements.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:23pt;"> </p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Reclassifications</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:23pt;">The Company reclassified $4.2 million from accrued expenses to accounts payable at <em style="font: inherit;"> December 31, 2023, </em>to conform to current presentation resulting in <em style="font: inherit;">no</em> effect to results of operations or cash flows.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:23pt;"> </p>
CY2024Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
300000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
0 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18598000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12907000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38368000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39749000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18598000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12907000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38368000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39749000 usd
CY2024Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
329000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
0 usd
CY2024Q2 us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
359000 usd
CY2023Q2 us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
0 usd
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
359000 usd
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
0 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
82000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
224000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
334000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
55000 usd
CY2024Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-112000 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-294000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-364000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-546000 usd
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
330000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1012000 usd
CY2024Q2 us-gaap Supplies
Supplies
112000 usd
CY2023Q4 us-gaap Supplies
Supplies
132000 usd
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
284000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
159000 usd
CY2024Q2 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
329000 usd
CY2023Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
0 usd
CY2024Q2 us-gaap Deposit Assets
DepositAssets
125000 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
237000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
145000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
137000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1325000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1677000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
110426000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
110646000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62057000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
61167000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48369000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49479000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
1800000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
2000000 usd
us-gaap Depreciation
Depreciation
3600000 usd
us-gaap Depreciation
Depreciation
4000000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
65000 usd
CY2024Q2 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
1165000 usd
CY2023Q4 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
1165000 usd
CY2024Q2 slng Equity Method Investment Accumulated Accretion
EquityMethodInvestmentAccumulatedAccretion
637000 usd
CY2023Q4 slng Equity Method Investment Accumulated Accretion
EquityMethodInvestmentAccumulatedAccretion
573000 usd
CY2024Q2 slng Equity Method Investment Net Remaining Basis Difference
EquityMethodInvestmentNetRemainingBasisDifference
528000 usd
CY2023Q4 slng Equity Method Investment Net Remaining Basis Difference
EquityMethodInvestmentNetRemainingBasisDifference
592000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2168000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3276000 usd
CY2024Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
620000 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
354000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
826000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
536000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3614000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4166000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
8594000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
9429000 usd
CY2024Q2 us-gaap Debt Current
DebtCurrent
1216000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
1682000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7378000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7747000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
100000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
400000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
200000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
800000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1200000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18585014
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18464929
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18581932
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18445775
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5170
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5170
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18590184
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18464929
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18587102
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18445775
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
27000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2174000 usd
us-gaap Net Income Loss
NetIncomeLoss
1496000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1090000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Interest Paid Net
InterestPaidNet
309000 usd
us-gaap Interest Paid Net
InterestPaidNet
334000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-403000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-207000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
486000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3043000 usd

Files In Submission

Name View Source Status
0001437749-24-025209-index-headers.html Edgar Link pending
0001437749-24-025209-index.html Edgar Link pending
0001437749-24-025209.txt Edgar Link pending
0001437749-24-025209-xbrl.zip Edgar Link pending
ex_680480.htm Edgar Link pending
ex_680481.htm Edgar Link pending
ex_680482.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
logo01.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
slng-20240630.xsd Edgar Link pending
slng20240630_10q.htm Edgar Link pending
slng-20240630_cal.xml Edgar Link unprocessable
slng-20240630_def.xml Edgar Link unprocessable
slng-20240630_lab.xml Edgar Link unprocessable
slng-20240630_pre.xml Edgar Link unprocessable
slng20240630_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable